PharmaCyte Biotech
PMCB
PMCB
33 hedge funds and large institutions have $643K invested in PharmaCyte Biotech in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Holders
33
Holding in Top 10
–
Calls
$115K
Puts
–
Top Buyers
| 1 | +$99.3K | |
| 2 | +$54.9K | |
| 3 | +$28.7K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$21.4K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$8.82K |
Top Sellers
| 1 | -$121K | |
| 2 | -$72.4K | |
| 3 | -$28.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$6.27K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$4.51K |
